Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop
RAPPID
Suivi en Vie Réelle de l'Activité Physique de Patients Présentant un Diabète de Type 1 Sportifs Equipés d'Une Pompe à Insuline Avec Délivrance Automatisée d'Insuline
1 other identifier
observational
87
1 country
4
Brief Summary
This is a non-interventional, prospective, multi-site study conducted in France among adults with type 1 diabetes mellitus using automated insulin delivery (AID) systems and engaging in at least two exercise sessions per week, each lasting at least 30 minutes. The main objective of this study is to describe the glycemic control of athletic participants with type 1 diabetes mellitus who use an insulin pump with AID and engage in physical exercise under real-life conditions. Two physician data collection time points are planned: the first occurs at baseline and includes demographic and clinical data, glycemic control during the month preceding inclusion, diabetes management, and information on usual physical exercise (duration, type, sport practiced, competition participation, and adherence to a specific diet). The second occurs at 1-month follow-up and involves downloading insulin pump and glucose sensor data, covering the period from 15 days before the first reported exercise session to 15 days after the last session. During the 1-month study period, participants will complete a paper logbook after each exercise session to document information such as the type of exercise, self-reported intensity using the modified Borg scale and the WHO physical activity intensity scale, duration, system adjustments, dietary intake, occurrence of hypoglycemia and associated symptoms, snacks consumed, and treatments administered for hypoglycemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedFirst Submitted
Initial submission to the registry
May 23, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedJanuary 26, 2026
May 1, 2025
10 months
May 23, 2025
January 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time Below Range
Percentage of time spent with glucose \<70 mg/dL and \<54 mg/dL before the exercise (within 2 hours prior), during exercise, during early recovery (within 3 hours after exercise), late recovery (from 3 hours after exercise to 8:00 a.m. the following day or until the next pre-exercise window, if closely), and during non-exercise periods
One month
Secondary Outcomes (6)
Time-in-Range
One month
Time Above Range
One month
Ajustement Practices
One month
ADDQoL questionnaire
At inclusion
DTSQs questionnaire
At inclusion
- +1 more secondary outcomes
Study Arms (1)
Adults with type 1 diabetes mellitus using AID and engaging in regular physical activity
Interventions
No intervention
Eligibility Criteria
The study population will be recruited by four specialized tertiary diabetes care centers (Vandœuvre-lès-Nancy, Strasbourg, Caen, and Mainvilliers).
You may qualify if:
- Adult participants with diabetes mellitus type 1
- User for at least 3 months of one the three automated insulin delivery systems available in France at the time of the study (Minimed 780G pump + Guardian 4 sensor + PID-IFB algorithm; or T:Slim X2 pump + Dexcom G6 sensor + Control-IQ algorithm; or mylife Ypsopump + Dexcom G6 sensor + CamAPS FX app)
- Engaged in regular physical activity as part of daily life (at least 2 structured sessions per week, each lasting more than 30 minutes)
- Able to download data from the pump
- Willing and able to complete the physical activity log and self-questionnaires in French
- Having received the information sheet and given their oral consent (non-opposition) to participate in the study and for their data processing
You may not qualify if:
- Participants currently enrolled in a clinical trial
- Pregnancy or breastfeeding women or women planning a pregnancy during the study
- Adults under legal protection (guardianship, curatorship, or judicial safeguard)
- Participants with decompensated retinopathy
- Participants with decompensated cardiac disease
- History of severe hypoglycemia during physical activity in the past 6 months
- Participants with unresolved diabetic foot trophic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
CHU of Caen
Caen, 14033, France
Institute of Diabetology
Mainvilliers, 28300, France
CHRU of Nancy
Nancy, 54511, France
University Hospitals of Strasbourg
Strasbourg, 67091, France
Related Publications (1)
Joubert M, Meyer L, Bekka S, Rakotoarisoa L, Scheyer N, Dreves B, Guerci B. Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study. Diabetes Obes Metab. 2025 Dec;27(12):7221-7231. doi: 10.1111/dom.70122. Epub 2025 Sep 9.
PMID: 40926369RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruno GUERCI, Professor, MD, PhD
CHRU Nancy and University of Lorraine, Nancy, france
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2025
First Posted
June 11, 2025
Study Start
March 5, 2024
Primary Completion
December 15, 2024
Study Completion
December 15, 2024
Last Updated
January 26, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
In accordance with the General Data Protection Regulation and French data protection law, the presentation of the results derived from data processing shall under no circumstances allow the direct or indirect identification of individuals participating in the research. In the event of publication of the research findings in a scientific journal, access to the data by an independent expert - including one appointed by a scientific publisher - shall only be granted through the interface provided or designated by the Data Controller, solely for the purpose of verifying or reproducing the analyses, and exclusively under the conditions defined for secure consultation and data handling.